This randomized phase III trial is studying chemotherapy and pelvic radiation therapy to see how well they work when given with or without additional chemotherapy in treating patients with high-risk early-stage cervical cancer after radical hysterectomy.
Contact site for start date.
Please contact ClinicalResearch@sutterhealth.org about Study RTOG 0724.
View study details on ClinicalTrials.gov
Females, 18 years and older, with histologically confirmed squamous, adenosquamous, or adenocarcinoma of the cervix.
June 01, 2018